Conference Coverage
Advertisement
Study investigators say that extended follow-up research on nivolumab consolidation is essential.
Dr. Paz-Ares shares his insights on the study's results and the remaining questions about ADCs in lung cancer treatment.
The CheckMate 9LA study evaluated first-line nivolumab plus ipilimumab with 2 cycles of platinum-doublet chemotherapy.
Researchers compared outcomes between patients with baseline stage III N2 and non-N2 NSCLC.
Most patients who received adjuvant osimertinib achieved MRD negativity.
More than half of patients in the study had psychological distress as well as elevated serum cortisol levels.
Researchers assessed patients' functional health and well-being across multiple physical and mental domains.
A pilot study evaluated neoadjuvant platinum, pemetrexed, and nivolumab followed by pleurectomy/decortication.
Study investigators say the results support further study of the bispecific T-cell engager in previously treated SCLC.
Dr. Spigel speaks about how the American Society of Clinical Oncology Annual Meeting inspires collaboration and discovery.
Narjust Florez, MD, FASCO, discusses her research on the unique needs of young patients with lung cancer.
Laila Gharzai, MD, discusses her research on the financial impacts of lung biomarker testing.
Dr. Singhi discusses practice-changing data and historic advancements in lung cancer.
Dr. Mehta discusses the study, which met its primary end point, and future directions for the research.
Hypercortisolism may play a key role in making type 2 diabetes difficult to manage.
A study highlights insurance barriers to continuous glucose monitoring among children with type 1 diabetes.
According to findings from the INHALE-3 study, inhaled insulin is a promising treatment for patients with T1D.
Samantha Armstrong, MD, and Karine Tawagi, MD, discuss the interview on the groundbreaking plenary presentation.
Nearly 80% of patients enrolled had epithelioid histology and 65% had an ECOG performance status of 1.
The use of tirzepatide in patients with obstructive sleep apnea and obesity improves both OSA severity and metabolic issues.
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2024 Mashup Media, LLC. All rights reserved.